# Intranasal Steroids and the Nasal Ocular Response

> **NCT00473915** · PHASE4 · COMPLETED · sponsor: **University of Chicago** · enrollment: 20 (estimated)

## Conditions studied

- Seasonal Allergic Rhinitis

## Interventions

- **DRUG:** fluticasone furoate

## Key facts

- **NCT ID:** NCT00473915
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2007-12
- **Final completion:** 2008-02
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2013-06-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00473915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00473915, "Intranasal Steroids and the Nasal Ocular Response". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00473915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*